EVA EDWARDS: Open Payments
NPI 1396964102 · MANCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,399 in 82 payments from 18 companies in 2025. Trend: 2023 $4,109 · 2024 $1,325 · 2025 $1,399
Food & beverage: $1,399
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $161 |
| ABBVIE INC. | 13 | $153 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $153 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Ardelyx, Inc. | 6 | $127 |
| Vanda Pharmaceuticals Inc. | 6 | $120 |
| Indivior Inc. | 6 | $117 |
| Alkermes, Inc. | 4 | $92 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Braeburn Inc. | 3 | $56 |
Products named: CAPLYTA, IBSRELA, SUBLOCADE, RELISTOR, ARISTADA, MAVYRET, HETLIOZ, Auvelity.
Industry payments across KY — which companies pay providers there.
